Edward Meinert, MA (Oxon), MSc, MBA, MPA, PhD, CEng, FBCS, EUR ING
Associate Professor of eHealth, Centre for Health Technology, University of Plymouth, UK
Dr Meinert is a research scientist trained in Public Health specializing in the use of digital health in preventive medicine. With his interdisciplinary background, Dr Meinert brings extensive professional experience in data science as well as implementation and evaluation of complex information systems. Dr Meinert has been awarded substantial funding to lead research investigations including high-impact research concerning the engineering and evaluation of digital health solutions and integrated health data ecosystems.
Dr Meinert is particularly interested in using clinical artificial intelligence to enhance population health insight, which is complemented by his work on critical enabling infrastructure including innovation and entrepreneurship, novel regulatory pathways, regulation, standards and intellectual property.
Editorial Board Members
Gunther Eysenbach, MD, MPH, FACMI
Gunther Eysenbach, MD, MPH, FACMI, has a life-long passion for information and communication technologies, knowledge translation and medical information, and has been recognized as the most impactful medical informatician in the world. He studied medicine, computer science, and public health, and, already as a medical student, wrote books and worked for a major scholarly publisher as an Editor. Dr Eysenbach is a visionary who recognized the importance of the internet for both medical information dissemination as well as for scholarly publishers in the 90s, became a pioneer of the gold Open-Access movement, created one of the first open-access journals, co-founded the OASPA (Open Access Scholarly Publishers Association), and built JMIR Publications, a respected global scholarly publishing firm known for quality and forward-thinking open science innovations (one of Canada’s Fastest Growing Companies).
Among his many innovations, Dr Eysenbach invented JMIRx, a series of "superjournals" where the vast majority of papers are published first on a preprint server, with “overlay" journals then competing to peer review and publish peer-reviewed "versions of record" for the best papers – first announced in Dr Eysenbach’s editorial here: https://www.jmir.org/2019/12/e17578/. This model captures the end goal in scholarly publishing: open science.
Additionally, Dr Eysenbach is the co-inventor of TrendMD, a company he co-founded as Chief Science Officer, which is another avenue to disseminate scientific information in a targeted manner. He spends most of his time as President of JMIR Publications, but also invests in innovative startups in medicine and science as an angel investor. He holds the position of Adjunct Professor at the University of Victoria.
Bernd Pohlmann-Eden, MD, PhD
Dr Bernd Pohlmann-Eden is a Canadian-German neuroscientist based in Toronto, Canada. He currently holds appointments as Adjunct Professor of Pharmacology and Toxicology at the University of Toronto, Canada, and as Professor of Neurology at Mannheim Hospital, University of Heidelberg, Germany. From 2002 to 2007, he was Medical Director and Chair of the Epilepsy Centre Bethel-Bielefeld in Germany. In his role as Director of the Epilepsy Program at Dalhousie University, Halifax, Canada, he developed new portals of care with a focus on early intervention and prospective cohorts. Under his leadership, the Halifax First Seizure Clinic flourished into an internationally recognized model of strategic innovation.
Dr Pohlmann-Eden’s research interests within neuroscience range from clinical epileptogenesis to brain network diseases and the overlap of neurological and psychiatric brain circuit disorders. He is driven by the vision to make the patient the expert and to optimize knowledge transfer. In this context, he developed a new innovative cognitive and behavioral science-based communication tool for patients, informed by lessons from the aviation industry (cross-industry thinking). Dr Pohlmann-Eden enthusiastically supports new concepts in eHealth with a focus on education and open science publishing. He has been an investigator in numerous clinical trials including the largest global epilepsy multicenter trial, the KOMET study. He delivers lectures worldwide and has authored more than 200 research papers.
Join the Editorial Board